Skip to main content

Gerard Marti Aguasca

Institutions of which they are part

Predoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Gerard Marti Aguasca

Institutions of which they are part

Predoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Antiagregación en infarto con elevación del ST revascularizado con stent: Efectividad y variabilidad de la práctica clínica. Subproyecto 1

IP: Ignacio Ferreira González
Collaborators: AIDA RIBERA SOLÉ, Gerard Marti Aguasca, Jordi Bañeras Rius, Bruno Garcia del Blanco
Funding agency: Instituto de Salud Carlos III
Funding: 80465
Reference: PI13/00399
Duration: 01/01/2014 - 30/06/2018

Red Cardiovascular

IP: -
Collaborators: Jorge Guillermo Romero Farina, José Antonio Barrabés Riu, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Joan Castell Conesa, Josep Pinar Sopena, Teresa González Alujas, Gisela Teixido i Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Gemma Cuberas Borros, Rosa María Lidón Corbi, Francesc Xavier Armengol Castells, Vicens Serra Garcia, Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno Garcia del Blanco, Pilar Tornos Mas, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Javier Inserte Igual, Red Cardiovascular, Laura Dos Subirá, Maria Nazarena Pizzi
Funding agency: Instituto de Salud Carlos III
Funding: 668059.76
Reference: RD12/0042/0021
Duration: 01/01/2013 - 30/06/2017

Eficacia y seguridad de la doble antiagregación comparada con la combinación de anticoagulación oral+doble antiagregación en pacientes con fibrilación auricular de bajo-moderado riesgo sometidos a la implantación de un stent coronario

IP: Antonia Sambola Ayala
Collaborators: Gerard Marti Aguasca, Bruno Garcia del Blanco, Pilar Tornos Mas
Funding agency: Ministerio Sanidad
Funding: 64900
Reference: EC11-473
Duration: 01/01/2012 - 31/12/2014

Características inmunohistoquímicas y moleculares del trombo resistente a la fibrinolisis

IP: Antonia Sambola Ayala
Collaborators: Gerard Marti Aguasca, Neus Bellera Gotarda, Imanol Otaegui Irurueta
Funding agency: Instituto de Salud Carlos III
Funding: 57475
Reference: PI09/01014
Duration: 01/01/2010 - 30/06/2014

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

Related professionals

Khloud Abdo Soliman Elsharawy

Khloud Abdo Soliman Elsharawy

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Habby Jawo Baldeh

Habby Jawo Baldeh

Maintenance staff and general services
Infectious Diseases
Read more
Imane EL Haddioui Assarraj

Imane EL Haddioui Assarraj

Maintenance staff and general services
Infectious Diseases
Read more
Maria Eugenia Palacio Lacambra

Maria Eugenia Palacio Lacambra

Postdoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.